Sales for chronic hepatitis B therapeutics 2014 and 2024 by major market

Published by Statista Research Department, Jan 1, 2016
This statistic shows the chronic hepatitis B therapeutics sales in 2014 and 2024, by major market. Sales for chronic hepatitis B therapeutics in the U.S. market were some 773 million U.S. dollars in 2014.

Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2016

Region

Worldwide

Survey time period

as of January 2016

Supplementary notes

All data is based on primary research interviews and surveys conducted with key opinion leaders (KOLs) and high-prescribing physicians in the countries included in this report.
* Forecast.
** EU5: Five major European pharmaceutical markets (France, Germany, Italy, Spain, and UK).

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical market worldwide "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market worldwide

Overview

6

Segments

6

Companies

8

R&D, patents, new products

7

Outlook

6

Review: COVID-19 response

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in RussiaGlobal pharmaceutical industryTop pharmaceutical drugsHealthcare in RussiaCoronavirus (COVID-19) in Russia
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.